Lista de obras - Radosław Mądry - Dominio Público Uruguay

Analysis of risk factors for recurrence after treatment of endometrial uterine cancer

artículo científico publicado en 2009

Badania kontrolne po leczeniu w najczęstszych nowotworach litych u dorosłych

artículo científico publicado en 2014

Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival

artículo científico publicado en 2016

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

artículo científico publicado en 2018

Comparison of the effects of endurance and endurance‑strength training programmes on the level of endothelial dysfunction in women with abdominal obesity: study protocol for a randomised controlled trial

artículo científico publicado en 2019

Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer.

artículo científico publicado en 2014

Dietary intake variability in the cycle of cytotoxic chemotherapy

artículo científico publicado en 2016

High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.

artículo científico publicado en 2012

Influence of body weight changes on survival in patients undergoing chemotherapy for epithelial ovarian cancer

artículo científico publicado en 2016

Link between diet and chemotherapy related gastrointestinal side effects

artículo científico publicado en 2017

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

artículo científico publicado en 2016

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

artículo científico publicado en 2011

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

scientific article published on 19 February 2020

P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

artículo científico publicado en 2003

Recommendations of Polish Gynecological Oncology Society concerning epithelial tumors of the ovary: ovarian cancer and borderline tumors

Recommendations of the Polish Gynecological Oncology Society for the diagnosis and treatment of ovarian cancer

artículo científico publicado en 2017

Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of cervical cancer

artículo científico publicado en 2017

Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of endometrial cancer

artículo científico publicado en 2017

Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of vulvar cancer

artículo científico publicado en 2017

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

artículo científico publicado en 2021

Results of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy

artículo científico publicado en 2016

Studies on selected molecular factors in endometrial cancers

artículo científico publicado en 2018

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study.

artículo científico publicado en 2008

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer.

artículo científico publicado en 2004

TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens.

artículo científico publicado en 2008

The Effect of Endurance and Endurance-Strength Training on Bone Mineral Density and Content in Abdominally Obese Postmenopausal Women: A Randomized Trial

artículo científico publicado en 2021

The expression of BRCA1, P53, KAI1, and Nm23 in ovaries of BRCA1 mutation carriers after prophylactic adnexectomy.

artículo científico publicado en 2013

[Evaluation of Cicatridine efficacy in healing and repairing process of uterine cervix, vagina and vulva--open no-randomized clinical study].

artículo científico publicado en 2008

[Influence of oncological treatment on fertility of women and pregnancy outcome]

artículo científico publicado en 2010

[Radioimmunotherapy in patients with ovarian cancer in complete remission after the first line surgery and chemotherapy after second look laparoscopy procedure]

artículo científico publicado en 2003

Lista de obras de Radosław Mądry

Analysis of risk factors for recurrence after treatment of endometrial uterine cancer

Badania kontrolne po leczeniu w najczęstszych nowotworach litych u dorosłych

Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

Comparison of the effects of endurance and endurance‑strength training programmes on the level of endothelial dysfunction in women with abdominal obesity: study protocol for a randomised controlled trial

Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer.

Dietary intake variability in the cycle of cytotoxic chemotherapy

High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.

Influence of body weight changes on survival in patients undergoing chemotherapy for epithelial ovarian cancer

Link between diet and chemotherapy related gastrointestinal side effects

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

Recommendations of Polish Gynecological Oncology Society concerning epithelial tumors of the ovary: ovarian cancer and borderline tumors

Recommendations of the Polish Gynecological Oncology Society for the diagnosis and treatment of ovarian cancer

Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of cervical cancer

Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of endometrial cancer

Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of vulvar cancer

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

Results of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy

Studies on selected molecular factors in endometrial cancers

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study.

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer.

TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens.

The Effect of Endurance and Endurance-Strength Training on Bone Mineral Density and Content in Abdominally Obese Postmenopausal Women: A Randomized Trial

The expression of BRCA1, P53, KAI1, and Nm23 in ovaries of BRCA1 mutation carriers after prophylactic adnexectomy.

[Evaluation of Cicatridine efficacy in healing and repairing process of uterine cervix, vagina and vulva--open no-randomized clinical study].

[Influence of oncological treatment on fertility of women and pregnancy outcome]

[Radioimmunotherapy in patients with ovarian cancer in complete remission after the first line surgery and chemotherapy after second look laparoscopy procedure]